Thanks for the post fouremm.
I'm sort of glad to hear that CD Venture has a significant position in RVX given that Christoph Boehringer of Boehringer Ingelheim is a managing director. To me it lends further credibility and support in the science of RVX just like Eastern, NGN and Hepalink.
Bright minds want a piece of the RVX pie.
GLTA
Toinv